Charles Fracchia is passionate about solving problems at the intersection of biological industry and national security in ways that inflect the trend for persistent defensive advantage.
CEO, Black Mesa Labs and
Mr. Charles Fracchia is the CEO of Black Mesa, a Boston-based company in stealth mode focusing on solving digital biosecurity challenges and improving manufacturing operations security. Black Mesa is building the Test Range, the first facility of its kind that allows public and private sector to identify, test, and train against emerging digital and biological threats to the biomanufacturing sector in a real-operating environment.
Mr. Fracchia is also the Co-Founder of BIO-ISAC, an international organization that addresses threats unique to the bioeconomy and enables coordination among stakeholders to facilitate a robust and secure industry.
Mr. Fracchia was the founder and CEO of BioBright, the company that created the first -and still only- end-to-end encrypted data collection and analysis from laboratory and biomanufacturing environments.received his graduate education between the MIT Media Lab and Harvard Medical School and obtained his bachelor’s degree from Imperial College London. Mr. Fracchia gained critical experience from his work at IBM Research and Ginkgo Bioworks where he was respectively the first synthetic biologist and first full-time person outside of the founding team. He has received a number of awards including MIT Technology Review’s 35 under 35, IBM PhD fellowships and the Extraordinary Minds fellowship.
In 2021, the U.S. Defense Advanced Research Projects Agency (DARPA) named Charles Fracchia to its Information Science and Technology (ISAT) Study Group.